ClinicalTrials.gg
CompletedNCT02942004Updated Oct 14, 2025Results posted

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

A Phase 3 interventional study of Placebo and SAGE-547 60 μg/kg/h in Postpartum Depression, sponsored by Supernus Pharmaceuticals, Inc.. Completed at 32 sites in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-10-14.

Sponsored by Supernus Pharmaceuticals, Inc. · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 220 studies in Depression, Postpartum with a site in United States — 38 open to participants now, 49 under way, 3 of them phase 3. Depression, Postpartum · United States.

Enrollment
75th of 198
138 · median 86
Started
2016
with 8 others
Phase 3
12 of 220
1 open now
Registered
79th of 220
by date
Lead sponsor
6 of 220
Supernus Pharmaceuticals, Inc.

Among the 220 studies in Depression, Postpartum with a site in United States, this one is the 75th largest by enrollment of the 198 interventional ones that give a count, is one of 9 that started in 2016, is one of 12 in phase 3, and was the 79th registered.

Depression, Postpartum

569 studies on the registry are indexed under Depression, Postpartum; 134 are open to participants now.

Browse Depression, Postpartum studies →

Open to participants now

38 of the 220 studies in Depression, Postpartum with a site in United States are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 87 Depression, Postpartum studies recruiting now, 54 (62%) set no upper age limit and 30 (34%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 220 studies in Depression, Postpartum with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study was to determine if SAGE-547 Injection infused intravenously at up to 90 micrograms per kilogram per hour (μg/kg/h) for 60 hours reduces depressive symptoms in participants with severe postpartum depression (PPD) compared to placebo injection as assessed by the change from baseline in Hamilton Rating Scale for Depression (HAM-D) total score.

03

Conditions studied

  • Postpartum Depression

Keywords

  • Severe Postpartum Depression
  • SAGE-547
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  • Participants must have ceased lactating at screening; or if still lactating or actively breastfeeding at screening, agreed to temporarily cease giving breastmilk to their infant(s) from just prior to receiving study drug through nine days (Day 12) after the end of the infusion
  • Participants had a major depressive episode that began no earlier than the third trimester and no later than the first 4 weeks following delivery, as diagnosed by Structured Clinical Interview for Axis I Disorders (SCID-I)
  • Participant had a HAM-D total score of ≥26 at screening and Day 1 (prior to dosing)
  • Participant was ≤6 months postpartum at screening
  • Participant was amenable to IV therapy

Key Exclusion Criteria:

  • Active psychosis
  • Attempted suicide associated with index case of postpartum depression
  • Medical history of bipolar disorders, schizophrenia, and/or schizoaffective disorder.

Note: Other protocol-defined inclusion/exclusion criteria applied.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
138 participants (actual)

Study arms

  • Placebo comparator
    Placebo

    Participants received infusion rates equivalent to either the 60 micrograms per kilogram per hour (μg/kg/h) or 90 μg/kg/h group.

    Drug: Placebo

  • Experimental
    SAGE-547 60 μg/kg/h

    Participants received a 4-hour titration period of 30 μg/kg/h (0 to 4 hours), then 60 μg/kg/h (4 to 56 hours), followed by a taper to 30 μg/kg/h (56 to 60 hours).

    Drug: SAGE-547 60 μg/kg/h

  • Experimental
    SAGE-547 90 μg/kg/h

    Participants received a 4-hour dose titration period of 30 μg/kg/h (0 to 4 hours), then 60 μg/kg/h (4 to 24 hours), then 90 μg/kg/h (24 to 52 hours), followed by a taper to 60 μg/kg/h (52 to 56 hours), and 30 μg/kg/h (56 to 60 hours).

    Drug: SAGE-547 90 μg/kg/h

Interventions

  • DrugPlacebo

    Intravenous infusion of matching placebo for either SAGE-547 60 μg/kg/h or 90 μg/kg/h.

  • DrugSAGE-547 60 μg/kg/h

    Drug page: Brexanolone

    Intravenous infusion of SAGE-547.

  • DrugSAGE-547 90 μg/kg/h

    Drug page: Brexanolone

    Intravenous infusion of SAGE-547.

06

What researchers measure

Primary outcomes

  1. Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score

    The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Baseline, Hour 60

Secondary outcomes

  1. Change From Baseline in HAM-D Total Score at Day 30

    The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Baseline, Day 30

  2. Change From Baseline in HAM-D Total Score

    The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Baseline, Hours 2, 4, 8, 12, 24, 36, 48, 72, and Days 7, 14, and 21

  3. Percentage of Participants With HAM-D Response

    The HAM-D response is defined as having a 50% or greater reduction from baseline in HAM-D total score. The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Hour 60, Days 7 and 30

  4. Percentage of Participants With HAM-D Remission

    The HAM-D remission is defined as having a HAM-D total score of ≤7. The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Hour 60, Days 7 and 30

  5. Change From Baseline in HAM-D Bech 6 Subscale

    The HAM-D Bech 6 subscale score is calculated as the sum of the following six items: Item # 1 (depressed mood), Item # 2 (feelings of guilt), Item # 7 (work and activities), Item # 8 (retardation), Item # 10 (anxiety psychic), and Item # 13 (general somatic symptoms). Each item is scored in a range of 0 to 2 or 0 to 4, with higher scores indicating a greater degree of depression. The scores were transformed to a 100-point scale with a higher score indicating a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Baseline, Hour 60, Days 7 and 30

  6. Change From Baseline in HAM-D Individual Item Scores

    The HAM-D comprises individual ratings of the following symptoms scored in a range of 0 to 2: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following symptoms are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

    Time frame: Baseline, Hour 2, Hour 4, Hour 8, Hour 12, Hour 24, Hour 36, Hour 48, Hour 60, Hour 72 and Days 7, 14, 21 and 30

  7. Change From Baseline at Key Time Points in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score

    The MADRS is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes in participants with mood disorders. It was designed as an adjunct to the HAM-D, to be more sensitive than the Hamilton Scale to the changes brought on by antidepressants and other forms of treatment. Each item yielded a score of 0 to 6. The MADRS total score was calculated as the sum of the 10 individual item scores, which ranged from 0 to 60. Higher MADRS scores indicates more severe depression. A negative change from baseline indicates less severe depression. A positive change from baseline indicates more severe depression.

    Time frame: Baseline, Hour 60, Days 7 and 30

  8. Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response

    The CGI-I item employs a 7-point Likert scale to measure the overall improvement in the participant's condition post-treatment. The investigator rated the participant's total improvement whether or not it was due entirely to drug treatment. Response choices include: 0 = not assessed, 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much worse, and 7 = very much worse. The CGI-I was only rated at post-treatment assessments. By definition, all CGI-I assessments were evaluated against baseline conditions. CGI-I response was defined as having a score of 1 (very much improved) or 2 (much improved).

    Time frame: Hour 60, Days 7 and 30

  9. Change From Baseline in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) Total Score

    The GAD-7 is a participant-rated, generalized anxiety symptom severity scale. Scoring for GAD-7 generalized anxiety is calculated by assigning scores of 0 = "not at all sure," 1 = "several days," 2 = "over half the days," and 3 = "nearly every day" to the response categories. The GAD-7 total score for the seven items ranges from 0 to 21, where a score of 0 to 4 = minimal anxiety, 5 to 9 = mild anxiety, 10 to 14 = moderate anxiety, and 15 to 21 = severe anxiety. The GAD-7 total score was calculated as the sum of the seven individual item scores. A negative change from baseline indicates less anxiety. A positive change from baseline indicates more anxiety.

    Time frame: Baseline, Hour 60, Days 7, 14, 21 and 30

  10. Percentage of Participants With Treatment-Emergent Adverse Events

    An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (eg, a clinically significant abnormal laboratory finding), symptom, or disease temporally associated with the use of a drug, whether or not it is considered related to the drug. A treatment-emergent AE (TEAE) is defined as an AE with onset on or after the start of study drug infusion, or any worsening of a pre-existing medical condition/AE with onset on or after the start of study drug infusion.

    Time frame: Up to approximately 37 days.

  11. Time to Change in Antidepressant Medication

    The time to first start or increase in the dose and time to first stop or decrease in the dose of any antidepressant medication.

    Time frame: Up to approximately 37 days.

07

Results

Posted Jun 13, 2019

Participant flow

Participants took part in the study at 32 centers in United States from 01 August 2016 to 19 October 2017.

Participant flow — Overall Study
MilestonePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Started464745
Participants who received study drug433841
Completed423536
Not completed4129
Withdrew: Withdrawal by subject023
Withdrew: Lost to follow-up112
Withdrew: Randomized but not dosed394

Outcome measures

PrimaryChange From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score

The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Baseline, Hour 60
Reported as:
Least squares mean · score on a scale
Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score-14.04 ± 1.148-19.54 ± 1.231-17.72 ± 1.193
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0013 · Least square (ls) mean difference: -5.50 · 95% CI -8.80 to -2.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0252 · Ls mean difference: -3.68 · 95% CI -6.90 to -0.47
SecondaryChange From Baseline in HAM-D Total Score at Day 30

The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Baseline, Day 30
Reported as:
Least squares mean · score on a scale
Change From Baseline in HAM-D Total Score at Day 30
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Change From Baseline in HAM-D Total Score at Day 30-13.82 ± 1.324-19.45 ± 1.435-17.62 ± 1.400
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0044 · Ls mean difference: -5.63 · 95% CI -9.46 to -1.79
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0481 · Ls mean difference: -3.79 · 95% CI -7.56 to -0.03
SecondaryChange From Baseline in HAM-D Total Score

The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Baseline, Hours 2, 4, 8, 12, 24, 36, 48, 72, and Days 7, 14, and 21
Reported as:
Least squares mean · score on a scale
Change From Baseline in HAM-D Total Score
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Change at Hour 2-5.04 ± 0.669-4.99 ± 0.721-4.89 ± 0.707
Change at Hour 4-6.88 ± 0.841-8.99 ± 0.902-7.18 ± 0.879
Change at Hour 8-8.13 ± 0.928-10.18 ± 0.994-8.50 ± 0.966
Change at Hour 12-9.79 ± 0.992-11.04 ± 1.069-9.07 ± 1.034
Change at Hour 24-10.71 ± 1.121-15.00 ± 1.199-13.03 ± 1.157
Change at Hour 36-12.58 ± 1.114-17.69 ± 1.203-13.93 ± 1.157
Change at Hour 48-13.55 ± 1.195-18.04 ± 1.282-16.89 ± 1.239
Change at Hour 72-14.67 ± 1.197-19.69 ± 1.285-17.19 ± 1.243
Change at Day 7-13.34 ± 1.268-17.41 ± 1.353-14.93 ± 1.315
Change at Day 14-14.64 ± 1.457-17.56 ± 1.586-15.64 ± 1.521
Change at Day 21-13.23 ± 1.380-18.15 ± 1.529-16.74 ± 1.451
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9591 · Ls mean difference: 0.05 · 95% CI -1.83 to 1.93
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8677 · Ls mean difference: 0.15 · 95% CI -1.66 to 1.97
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0827 · Ls mean difference: -2.11 · 95% CI -4.51 to 0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7968 · Ls mean difference: -0.30 · 95% CI -2.62 to 2.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1292 · Ls mean difference: -2.04 · 95% CI -4.69 to 0.61
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7801 · Ls mean difference: -0.36 · 95% CI -2.94 to 2.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3840 · Ls mean difference: -1.25 · 95% CI -4.10 to 1.59
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6097 · Ls mean difference: 0.71 · 0.71% CI -2.05 to 3.48
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0094 · Ls mean difference: -4.28 · 95% CI -7.50 to -1.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1440 · Ls mean difference: -2.32 · 95% CI -5.45 to 0.80
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0020 · Ls mean difference: -5.12 · 95% CI -8.33 to -1.91
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3906 · Ls mean difference: -1.36 · 95% CI -4.47 to 1.76
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0110 · Ls mean difference: -4.49 · 95% CI -7.93 to -1.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0511 · Ls mean difference: -3.33 · 95% CI -6.68 to 0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0046 · Ls mean difference: -5.02 · 95% CI -8.47 to -1.58
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1389 · Ls mean difference: -2.53 · 95% CI -5.88 to 0.83
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0288 · Ls mean difference: -4.07 · 95% CI -7.71 to -0.43
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3799 · Ls mean difference: -1.58 · 95% CI -5.15 to 1.98
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1747 · Ls mean difference: -2.92 · 95% CI -7.16 to 1.32
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6310 · Ls mean difference: -1.00 · 95% CI -5.13 to 3.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0178 · Ls mean difference: -4.92 · 95% CI -8.98 to -0.87
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0786 · Ls mean difference: -3.51 · 95% CI -7.43 to 0.41
SecondaryPercentage of Participants With HAM-D Response

The HAM-D response is defined as having a 50% or greater reduction from baseline in HAM-D total score. The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Hour 60, Days 7 and 30
Reported as:
Number · percentage of participants
Percentage of Participants With HAM-D Response
percentage of participantsPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 6055.886.574.4
Day 748.868.452.5
Day 3050.082.969.4
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0052 · Odds ratio (or): 5.4 · 95% CI 1.7 to 17.4
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0493 · Odds ratio (or): 2.6 · 95% CI 1.0 to 6.9
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0572 · Odds ratio (or): 2.5 · 95% CI 1.0 to 6.5
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.6768 · Odds ratio (or): 1.2 · 95% CI 0.5 to 3.0
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0035 · Odds ratio (or): 5.4 · 95% CI 1.7 to 16.8
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0347 · Odds ratio (or): 2.9 · 95% CI 1.1 to 7.8
SecondaryPercentage of Participants With HAM-D Remission

The HAM-D remission is defined as having a HAM-D total score of ≤7. The HAM-D Total Score comprises a sum of the 17 individual item scores. Items scored in a range of 0 to 2 include: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following items are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. The Total Score can range from 0 to 52, and higher scores indicate a greater degree of depression. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Hour 60, Days 7 and 30
Reported as:
Number · percentage of participants
Percentage of Participants With HAM-D Remission
percentage of participantsPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 6016.351.430.8
Day 730.231.620.0
Day 3031.048.638.9
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0011 · Odds ratio (or): 6.0 · 95% CI 2.1 to 17.8
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0828 · Odds ratio (or): 2.6 · 95% CI 0.9 to 7.6
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.7749 · Odds ratio (or): 1.2 · 95% CI 0.4 to 3.1
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.3401 · Odds ratio (or): 0.6 · 95% CI 0.2 to 1.7
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.1052 · Odds ratio (or): 2.3 · 95% CI 0.8 to 6.0
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.3507 · Odds ratio (or): 1.6 · 95% CI 0.6 to 4.2
SecondaryChange From Baseline in HAM-D Bech 6 Subscale

The HAM-D Bech 6 subscale score is calculated as the sum of the following six items: Item # 1 (depressed mood), Item # 2 (feelings of guilt), Item # 7 (work and activities), Item # 8 (retardation), Item # 10 (anxiety psychic), and Item # 13 (general somatic symptoms). Each item is scored in a range of 0 to 2 or 0 to 4, with higher scores indicating a greater degree of depression. The scores were transformed to a 100-point scale with a higher score indicating a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Baseline, Hour 60, Days 7 and 30
Reported as:
Least squares mean · score on a scale
Change From Baseline in HAM-D Bech 6 Subscale
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 60-32.60 ± 2.962-44.67 ± 3.178-38.49 ± 3.081
Day 7-29.43 ± 3.116-38.52 ± 3.327-31.67 ± 3.236
Day 30-30.94 ± 3.122-42.62 ± 3.385-39.20 ± 3.304
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0058 · Ls mean difference: -12.07 · 95% CI -20.58 to -3.56
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1622 · Ls mean difference: -5.89 · 95% CI -14.19 to 2.41
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0462 · Ls mean difference: -9.09 · 95% CI -18.02 to -0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6124 · Ls mean difference: -2.24 · 95% CI -10.97 to 6.49
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0116 · Ls mean difference: -11.68 · 95% CI -20.71 to -2.66
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0667 · Ls mean difference: -8.26 · 95% CI -17.10 to 0.58
SecondaryChange From Baseline in HAM-D Individual Item Scores

The HAM-D comprises individual ratings of the following symptoms scored in a range of 0 to 2: insomnia (early, middle, late), somatic symptoms (gastrointestinal and general), genital symptoms, loss of weight, and insight. The following symptoms are scored in a range of 0 to 4: agitation, depressed mood, feelings of guilt, suicide, work and activities, retardation, anxiety (psychic and somatic), and hypochondriasis. Higher scores indicate a greater degree of depression. A negative change from baseline indicates less depression. A positive change from baseline indicates more depression.

Time frame:
Baseline, Hour 2, Hour 4, Hour 8, Hour 12, Hour 24, Hour 36, Hour 48, Hour 60, Hour 72 and Days 7, 14, 21 and 30
Reported as:
Least squares mean · score on a scale
Change From Baseline in HAM-D Individual Item Scores
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Depressed Mood, Change at Hour 2-0.54 ± 0.133-0.54 ± 0.143-0.45 ± 0.139
Depressed Mood, Change at Hour 4-0.79 ± 0.165-0.97 ± 0.176-0.79 ± 0.171
Depressed Mood, Change at Hour 8-1.02 ± 0.166-1.23 ± 0.178-0.94 ± 0.172
Depressed Mood, Change at Hour 12-1.33 ± 0.170-1.50 ± 0.184-1.15 ± 0.177
Depressed Mood, Change at Hour 24-1.40 ± 0.163-1.40 ± 0.175-1.47 ± 0.169
Depressed Mood, Change at Hour 36-1.47 ± 0.170-2.03 ± 0.184-1.49 ± 0.176
Depressed Mood, Change at Hour 48-1.58 ± 0.173-2.07 ± 0.186-1.84 ± 0.180
Depressed Mood, Change at Hour 60-1.56 ± 0.169-2.27 ± 0.181-1.92 ± 0.176
Depressed Mood, Change at Hour 72-1.75 ± 0.162-2.32 ± 0.174-1.97 ± 0.169
Depressed Mood, Change at Day 7-1.49 ± 0.170-1.94 ± 0.182-1.55 ± 0.177
Depressed Mood, Change at Day 14-1.53 ± 0.205-2.06 ± 0.225-1.65 ± 0.213
Depressed Mood, Change at Day 21-1.48 ± 0.204-1.79 ± 0.229-1.75 ± 0.214
Depressed Mood, Change at Day 30-1.53 ± 0.170-2.19 ± 0.186-1.97 ± 0.183
Feelings of Guilt, Change at Hour 2-0.46 ± 0.133-0.54 ± 0.143-0.40 ± 0.138
Feelings of Guilt, Change at Hour 4-0.70 ± 0.157-1.12 ± 0.168-0.84 ± 0.162
Feelings of Guilt, Change at Hour 8-0.84 ± 0.162-1.25 ± 0.173-0.94 ± 0.168
Feelings of Guilt, Change at Hour 12-1.04 ± 0.164-1.25 ± 0.178-0.76 ± 0.171
Feelings of Guilt, Change at Hour 24-1.04 ± 0.162-1.50 ± 0.173-1.03 ± 0.167
Feelings of Guilt, Change at Hour 36-1.23 ± 0.150-1.59 ± 0.162-1.26 ± 0.156
Feelings of Guilt, Change at Hour 48-1.25 ± 0.152-1.64 ± 0.163-1.60 ± 0.158
Feelings of Guilt, Change at Hour 60-1.23 ± 0.149-1.68 ± 0.160-1.63 ± 0.155
Feelings of Guilt, Change at Hour 72-1.42 ± 0.145-1.69 ± 0.157-1.57 ± 0.152
Feelings of Guilt, Change at Day 7-1.18 ± 0.152-1.38 ± 0.163-1.36 ± 0.159
Feelings of Guilt, Change at Day 14-1.33 ± 0.158-1.49 ± 0.173-1.56 ± 0.169
Feelings of Guilt, Change at Day 21-1.10 ± 0.162-1.51 ± 0.181-1.51 ± 0.171
Feelings of Guilt, Change at Day 30-1.40 ± 0.149-1.61 ± 0.163-1.62 ± 0.161
Suicide, Change at Hour 2-0.57 ± 0.101-0.87 ± 0.107-0.48 ± 0.104
Suicide, Change at Hour 4-0.64 ± 0.098-0.92 ± 0.105-0.61 ± 0.101
Suicide, Change at Hour 8-0.81 ± 0.088-1.00 ± 0.094-0.63 ± 0.091
Suicide, Change at Hour 12-0.92 ± 0.089-0.89 ± 0.096-0.66 ± 0.092
Suicide, Change at Hour 24-0.87 ± 0.086-0.96 ± 0.092-0.68 ± 0.088
Suicide, Change at Hour 36-0.90 ± 0.068-1.00 ± 0.074-0.75 ± 0.071
Suicide, Change at Hour 48-0.88 ± 0.063-0.94 ± 0.069-0.95 ± 0.066
Suicide, Change at Hour 60-0.81 ± 0.065-1.03 ± 0.071-0.98 ± 0.069
Suicide, Change at Hour 72-0.88 ± 0.068-1.01 ± 0.074-0.90 ± 0.071
Suicide, Change at Day 7-0.71 ± 0.089-0.90 ± 0.095-0.77 ± 0.093
Suicide, Change at Day 14-0.92 ± 0.084-0.99 ± 0.093-0.80 ± 0.090
Suicide, Change at Day 21-0.61 ± 0.133-0.80 ± 0.152-0.88 ± 0.141
Suicide, Change at Day 30-0.76 ± 0.080-0.99 ± 0.088-0.88 ± 0.086
Insomnia - Early, Change at Hour 2-0.27 ± 0.078-0.04 ± 0.084-0.19 ± 0.082
Insomnia - Early, Change at Hour 4-0.29 ± 0.097-0.22 ± 0.104-0.29 ± 0.100
Insomnia - Early, Change at Hour 8-0.29 ± 0.103-0.17 ± 0.110-0.36 ± 0.107
Insomnia - Early, Change at Hour 12-0.22 ± 0.092-0.25 ± 0.100-0.26 ± 0.097
Insomnia - Early, Change at Hour 24-0.47 ± 0.138-1.10 ± 0.149-0.87 ± 0.142
Insomnia - Early, Change at Hour 36-0.55 ± 0.142-1.16 ± 0.155-0.84 ± 0.147
Insomnia - Early, Change at Hour 48-0.76 ± 0.144-1.07 ± 0.155-1.27 ± 0.149
Insomnia - Early, Change at Hour 60-0.85 ± 0.140-1.10 ± 0.151-1.19 ± 0.146
Insomnia - Early, Change at Hour 72-0.57 ± 0.142-0.96 ± 0.153-0.91 ± 0.148
Insomnia - Early, Change at Day 7-0.69 ± 0.144-1.20 ± 0.154-0.97 ± 0.150
Insomnia - Early, Change at Day 14-0.97 ± 0.174-1.19 ± 0.192-1.06 ± 0.182
Insomnia - Early, Change at Day 21-0.69 ± 0.154-1.28 ± 0.173-1.11 ± 0.160
Insomnia - Early, Change at Day 30-0.67 ± 0.141-1.34 ± 0.155-1.09 ± 0.153
Insomnia - Middle, Change at Hour 2-0.13 ± 0.0730.03 ± 0.078-0.17 ± 0.076
Insomnia - Middle, Change at Hour 4-0.16 ± 0.096-0.21 ± 0.102-0.24 ± 0.099
Insomnia - Middle, Change at Hour 8-0.20 ± 0.099-0.16 ± 0.105-0.32 ± 0.102
Insomnia - Middle, Change at Hour 12-0.16 ± 0.091-0.18 ± 0.098-0.22 ± 0.095
Insomnia - Middle, Change at Hour 24-0.57 ± 0.135-0.98 ± 0.145-0.93 ± 0.139
Insomnia - Middle, Change at Hour 36-0.74 ± 0.130-1.03 ± 0.141-1.02 ± 0.135
Insomnia - Middle, Change at Hour 48-0.90 ± 0.132-1.17 ± 0.142-1.19 ± 0.137
Insomnia - Middle, Change at Hour 60-0.83 ± 0.130-1.22 ± 0.140-1.23 ± 0.135
Insomnia - Middle, Change at Hour 72-0.93 ± 0.132-1.22 ± 0.143-1.09 ± 0.138
Insomnia - Middle, Change at Day 7-0.95 ± 0.128-1.05 ± 0.136-0.87 ± 0.133
Insomnia - Middle, Change at Day 14-0.72 ± 0.146-1.36 ± 0.161-0.98 ± 0.154
Insomnia - Middle, Change at Day 21-0.77 ± 0.146-1.27 ± 0.164-0.90 ± 0.152
Insomnia - Middle, Change at Day 30-0.78 ± 0.134-1.21 ± 0.147-0.99 ± 0.144
Insomnia - Late, Change at Hour 2-0.16 ± 0.0900.01 ± 0.096-0.22 ± 0.094
Insomnia - Late, Change at Hour 4-0.16 ± 0.104-0.12 ± 0.111-0.34 ± 0.108
Insomnia - Late, Change at Hour 8-0.14 ± 0.103-0.20 ± 0.110-0.37 ± 0.106
Insomnia - Late, Change at Hour 12-0.16 ± 0.103-0.01 ± 0.111-0.31 ± 0.107
Insomnia - Late, Change at Hour 24-0.68 ± 0.123-0.94 ± 0.133-0.95 ± 0.127
Insomnia - Late, Change at Hour 36-0.75 ± 0.127-0.91 ± 0.139-0.90 ± 0.132
Insomnia - Late, Change at Hour 48-0.89 ± 0.125-1.16 ± 0.135-1.15 ± 0.130
Insomnia - Late, Change at Hour 60-0.89 ± 0.121-1.16 ± 0.130-1.22 ± 0.126
Insomnia - Late, Change at Hour 72-1.07 ± 0.121-1.13 ± 0.131-1.12 ± 0.126
Insomnia - Late, Change at Day 7-0.89 ± 0.126-0.80 ± 0.135-1.04 ± 0.132
Insomnia - Late, Change at Day 14-0.79 ± 0.155-0.96 ± 0.172-0.86 ± 0.164
Insomnia - Late, Change at Day 21-0.77 ± 0.157-0.89 ± 0.176-0.74 ± 0.164
Insomnia - Late, Change at Day 30-0.77 ± 0.130-1.03 ± 0.143-1.09 ± 0.140
Work and Activities, Change at Hour 2-0.30 ± 0.105-0.43 ± 0.113-0.25 ± 0.111
Work and Activities, Change at Hour 4-0.51 ± 0.126-0.74 ± 0.135-0.43 ± 0.131
Work and Activities, Change at Hour 8-0.81 ± 0.160-0.95 ± 0.170-0.67 ± 0.165
Work and Activities, Change at Hour 12-1.02 ± 0.160-1.20 ± 0.173-0.83 ± 0.166
Work and Activities, Change at Hour 24-1.07 ± 0.169-1.19 ± 0.180-1.04 ± 0.174
Work and Activities, Change at Hour 36-1.39 ± 0.162-1.77 ± 0.176-1.09 ± 0.168
Work and Activities, Change at Hour 48-1.51 ± 0.179-1.80 ± 0.192-1.57 ± 0.185
Work and Activities, Change at Hour 60-1.46 ± 0.171-2.04 ± 0.184-1.70 ± 0.178
Work and Activities, Change at Hour 72-1.67 ± 0.164-2.18 ± 0.177-1.67 ± 0.171
Work and Activities, Change at Day 7-1.39 ± 0.176-1.82 ± 0.187-1.57 ± 0.182
Work and Activities, Change at Day 14-1.58 ± 0.198-1.57 ± 0.218-1.60 ± 0.208
Work and Activities, Change at Day 21-1.35 ± 0.191-1.96 ± 0.214-1.87 ± 0.200
Work and Activities, Change at Day 30-1.55 ± 0.174-2.08 ± 0.189-1.93 ± 0.185
Retardation, Change at Hour 2-0.18 ± 0.0840.17 ± 0.090-0.01 ± 0.087
Retardation, Change at Hour 4-0.34 ± 0.090-0.02 ± 0.096-0.03 ± 0.093
Retardation, Change at Hour 8-0.36 ± 0.092-0.20 ± 0.098-0.16 ± 0.095
Retardation, Change at Hour 12-0.57 ± 0.099-0.47 ± 0.107-0.42 ± 0.103
Retardation, Change at Hour 24-0.48 ± 0.092-0.47 ± 0.099-0.47 ± 0.095
Retardation, Change at Hour 36-0.71 ± 0.103-0.87 ± 0.112-0.65 ± 0.107
Retardation, Change at Hour 48-0.57 ± 0.098-0.70 ± 0.105-0.60 ± 0.101
Retardation, Change at Hour 60-0.76 ± 0.090-0.84 ± 0.097-0.74 ± 0.094
Retardation, Change at Hour 72-0.67 ± 0.092-0.87 ± 0.099-0.80 ± 0.096
Retardation, Change at Day 7-0.67 ± 0.091-1.02 ± 0.097-0.70 ± 0.095
Retardation, Change at Day 14-0.74 ± 0.117-0.87 ± 0.128-0.77 ± 0.123
Retardation, Change at Day 21-0.72 ± 0.104-1.05 ± 0.115-0.81 ± 0.108
Retardation, Change at Day 30-0.66 ± 0.088-1.08 ± 0.096-0.91 ± 0.095
Agitation, Change at Hour 2-0.46 ± 0.108-0.52 ± 0.115-0.45 ± 0.111
Agitation, Change at Hour 4-0.56 ± 0.103-0.70 ± 0.109-0.52 ± 0.106
Agitation, Change at Hour 8-0.51 ± 0.112-0.68 ± 0.119-0.55 ± 0.116
Agitation, Change at Hour 12-0.56 ± 0.114-0.65 ± 0.123-0.59 ± 0.118
Agitation, Change at Hour 24-0.54 ± 0.108-0.86 ± 0.115-0.69 ± 0.110
Agitation, Change at Hour 36-0.63 ± 0.111-0.82 ± 0.121-0.74 ± 0.115
Agitation, Change at Hour 48-0.74 ± 0.098-0.78 ± 0.105-0.78 ± 0.102
Agitation, Change at Hour 60-0.58 ± 0.105-0.85 ± 0.113-0.70 ± 0.110
Agitation, Change at Hour 72-0.65 ± 0.112-0.85 ± 0.120-0.82 ± 0.116
Agitation, Change at Day 7-0.60 ± 0.098-0.78 ± 0.104-0.66 ± 0.102
Agitation, Change at Day 14-0.87 ± 0.114-0.75 ± 0.126-0.82 ± 0.121
Agitation, Change at Day 21-0.61 ± 0.142-0.69 ± 0.161-0.76 ± 0.149
Agitation, Change at Day 30-0.64 ± 0.112-0.80 ± 0.122-0.62 ± 0.121
Anxiety Psychic, Change at Hour 2-0.60 ± 0.134-0.70 ± 0.144-0.76 ± 0.140
Anxiety Psychic, Change at Hour 4-0.90 ± 0.158-1.26 ± 0.169-1.12 ± 0.164
Anxiety Psychic, Change at Hour 8-1.25 ± 0.161-1.41 ± 0.172-1.22 ± 0.167
Anxiety Psychic, Change at Hour 12-1.39 ± 0.154-1.52 ± 0.167-1.35 ± 0.161
Anxiety Psychic, Change at Hour 24-1.16 ± 0.148-1.79 ± 0.159-1.59 ± 0.153
Anxiety Psychic, Change at Hour 36-1.37 ± 0.149-1.99 ± 0.162-1.41 ± 0.155
Anxiety Psychic, Change at Hour 48-1.41 ± 0.149-1.86 ± 0.161-1.71 ± 0.156
Anxiety Psychic, Change at Hour 60-1.48 ± 0.141-1.97 ± 0.152-1.64 ± 0.149
Anxiety Psychic, Change at Hour 72-1.55 ± 0.152-1.84 ± 0.164-1.61 ± 0.159
Anxiety Psychic, Change at Day 7-1.25 ± 0.149-1.44 ± 0.160-1.30 ± 0.156
Anxiety Psychic, Change at Day 14-1.42 ± 0.184-1.45 ± 0.204-1.17 ± 0.195
Anxiety Psychic, Change at Day 21-1.17 ± 0.197-1.26 ± 0.221-1.34 ± 0.207
Anxiety Psychic, Change at Day 30-1.15 ± 0.161-1.45 ± 0.176-1.43 ± 0.173
Anxiety Somatic, Change at Hour 2-0.56 ± 0.133-0.67 ± 0.142-0.75 ± 0.137
Anxiety Somatic, Change at Hour 4-0.86 ± 0.144-1.09 ± 0.154-0.88 ± 0.149
Anxiety Somatic, Change at Hour 8-0.79 ± 0.135-1.22 ± 0.145-1.05 ± 0.140
Anxiety Somatic, Change at Hour 12-0.86 ± 0.130-1.16 ± 0.141-0.91 ± 0.135
Anxiety Somatic, Change at Hour 24-0.77 ± 0.116-1.24 ± 0.125-1.12 ± 0.120
Anxiety Somatic, Change at Hour 36-0.86 ± 0.127-1.34 ± 0.140-1.08 ± 0.133
Anxiety Somatic, Change at Hour 48-0.86 ± 0.125-1.42 ± 0.136-1.20 ± 0.131
Anxiety Somatic, Change at Hour 60-1.00 ± 0.122-1.58 ± 0.132-1.31 ± 0.128
Anxiety Somatic, Change at Hour 72-0.91 ± 0.131-1.58 ± 0.142-1.29 ± 0.137
Anxiety Somatic, Change at Day 7-0.91 ± 0.134-1.28 ± 0.143-0.98 ± 0.140
Anxiety Somatic, Change at Day 14-0.70 ± 0.153-1.08 ± 0.169-0.88 ± 0.162
Anxiety Somatic, Change at Day 21-0.94 ± 0.155-1.40 ± 0.175-1.05 ± 0.163
Anxiety Somatic, Change at Day 30-0.80 ± 0.151-1.40 ± 0.166-0.99 ± 0.163
Somatic Symptoms GI, Change at Hour 2-0.28 ± 0.110-0.29 ± 0.118-0.30 ± 0.114
Somatic Symptoms GI, Change at Hour 4-0.28 ± 0.103-0.55 ± 0.111-0.44 ± 0.107
Somatic Symptoms GI, Change at Hour 8-0.42 ± 0.109-0.60 ± 0.117-0.57 ± 0.113
Somatic Symptoms GI, Change at Hour 12-0.51 ± 0.111-0.79 ± 0.121-0.56 ± 0.116
Somatic Symptoms GI, Change at Hour 24-0.47 ± 0.115-0.88 ± 0.123-0.79 ± 0.118
Somatic Symptoms GI, Change at Hour 36-0.54 ± 0.111-1.14 ± 0.122-0.78 ± 0.116
Somatic Symptoms GI, Change at Hour 48-0.61 ± 0.110-1.16 ± 0.119-0.84 ± 0.115
Somatic Symptoms GI, Change at Hour 60-0.82 ± 0.100-1.24 ± 0.109-0.96 ± 0.106
Somatic Symptoms GI, Change at Hour 72-0.68 ± 0.102-1.23 ± 0.111-1.01 ± 0.107
Somatic Symptoms GI, Change at Day 7-0.63 ± 0.114-1.00 ± 0.123-0.66 ± 0.119
Somatic Symptoms GI, Change at Day 14-0.77 ± 0.126-1.03 ± 0.139-0.89 ± 0.134
Somatic Symptoms GI, Change at Day 21-0.70 ± 0.132-1.17 ± 0.149-0.91 ± 0.139
Somatic Symptoms GI, Change at Day 30-0.82 ± 0.112-1.14 ± 0.123-0.91 ± 0.121
Somatic Symptoms General, Change at Hour 2-0.23 ± 0.086-0.28 ± 0.092-0.14 ± 0.089
Somatic Symptoms General, Change at Hour 4-0.27 ± 0.093-0.44 ± 0.099-0.33 ± 0.096
Somatic Symptoms General, Change at Hour 8-0.27 ± 0.093-0.33 ± 0.099-0.28 ± 0.096
Somatic Symptoms General, Change at Hour 12-0.51 ± 0.108-0.50 ± 0.117-0.49 ± 0.113
Somatic Symptoms General, Change at Hour 24-0.60 ± 0.119-0.67 ± 0.127-0.55 ± 0.122
Somatic Symptoms General, Change at Hour 36-0.64 ± 0.111-0.70 ± 0.122-0.79 ± 0.116
Somatic Symptoms General, Change at Hour 48-0.67 ± 0.113-1.05 ± 0.122-0.90 ± 0.117
Somatic Symptoms General, Change at Hour 60-0.78 ± 0.111-1.06 ± 0.120-0.95 ± 0.117
Somatic Symptoms General, Change at Hour 72-0.81 ± 0.113-1.26 ± 0.121-1.00 ± 0.117
Somatic Symptoms General, Change at Day 7-0.62 ± 0.121-0.91 ± 0.129-0.61 ± 0.125
Somatic Symptoms General, Change at Day 14-0.64 ± 0.138-0.92 ± 0.152-0.59 ± 0.144
Somatic Symptoms General, Change at Day 21-0.55 ± 0.138-1.04 ± 0.154-0.72 ± 0.144
Somatic Symptoms General, Change at Day 30-0.66 ± 0.129-1.00 ± 0.140-0.95 ± 0.137
Genital Symptoms, Change at Hour 20.00 ± 0.0550.00 ± 0.059-0.16 ± 0.057
Genital Symptoms, Change at Hour 40.00 ± 0.067-0.11 ± 0.072-0.13 ± 0.069
Genital Symptoms, Change at Hour 8-0.07 ± 0.087-0.16 ± 0.093-0.16 ± 0.090
Genital Symptoms, Change at Hour 12-0.07 ± 0.075-0.08 ± 0.082-0.24 ± 0.079
Genital Symptoms, Change at Hour 24-0.16 ± 0.100-0.28 ± 0.106-0.28 ± 0.102
Genital Symptoms, Change at Hour 36-0.23 ± 0.102-0.46 ± 0.111-0.51 ± 0.106
Genital Symptoms, Change at Hour 48-0.35 ± 0.107-0.46 ± 0.115-0.63 ± 0.110
Genital Symptoms, Change at Hour 60-0.35 ± 0.108-0.48 ± 0.116-0.67 ± 0.112
Genital Symptoms, Change at Hour 72-0.32 ± 0.107-0.57 ± 0.115-0.72 ± 0.110
Genital Symptoms, Change at Day 7-0.51 ± 0.113-0.71 ± 0.120-0.79 ± 0.117
Genital Symptoms, Change at Day 14-0.49 ± 0.131-0.70 ± 0.144-0.83 ± 0.138
Genital Symptoms, Change at Day 21-0.68 ± 0.141-0.90 ± 0.159-0.87 ± 0.147
Genital Symptoms, Change at Day 30-0.82 ± 0.131-0.97 ± 0.143-0.95 ± 0.140
Hypochondriasis, Change at Hour 2-0.23 ± 0.105-0.29 ± 0.113-0.34 ± 0.109
Hypochondriasis, Change at Hour 4-0.32 ± 0.111-0.39 ± 0.119-0.34 ± 0.116
Hypochondriasis, Change at Hour 8-0.23 ± 0.114-0.47 ± 0.122-0.41 ± 0.118
Hypochondriasis, Change at Hour 12-0.32 ± 0.109-0.41 ± 0.118-0.44 ± 0.114
Hypochondriasis, Change at Hour 24-0.39 ± 0.105-0.55 ± 0.112-0.48 ± 0.109
Hypochondriasis, Change at Hour 36-0.39 ± 0.104-0.61 ± 0.113-0.49 ± 0.109
Hypochondriasis, Change at Hour 48-0.49 ± 0.105-0.63 ± 0.113-0.58 ± 0.109
Hypochondriasis, Change at Hour 60-0.49 ± 0.100-0.60 ± 0.108-0.59 ± 0.105
Hypochondriasis, Change at Hour 72-0.60 ± 0.098-0.66 ± 0.106-0.55 ± 0.103
Hypochondriasis, Change at Day 7-0.49 ± 0.095-0.68 ± 0.102-0.58 ± 0.100
Hypochondriasis, Change at Day 14-0.54 ± 0.120-0.59 ± 0.132-0.51 ± 0.127
Hypochondriasis, Change at Day 21-0.84 ± 0.107-0.80 ± 0.119-0.57 ± 0.114
Hypochondriasis, Change at Day 30-0.60 ± 0.099-0.66 ± 0.109-0.60 ± 0.108
Loss of Weight, Change at Hour 2-0.05 ± 0.0570.03 ± 0.0610.06 ± 0.059
Loss of Weight, Change at Hour 4-0.07 ± 0.052-0.04 ± 0.0550.01 ± 0.054
Loss of Weight, Change at Hour 8-0.07 ± 0.060-0.02 ± 0.064-0.04 ± 0.062
Loss of Weight, Change at Hour 12-0.09 ± 0.0680.03 ± 0.074-0.09 ± 0.071
Loss of Weight, Change at Hour 24-0.07 ± 0.084-0.12 ± 0.090-0.24 ± 0.086
Loss of Weight, Change at Hour 36-0.14 ± 0.076-0.10 ± 0.082-0.19 ± 0.079
Loss of Weight, Change at Hour 48-0.05 ± 0.083-0.12 ± 0.089-0.26 ± 0.086
Loss of Weight, Change at Hour 60-0.09 ± 0.095-0.26 ± 0.102-0.35 ± 0.098
Loss of Weight, Change at Hour 72-0.14 ± 0.090-0.20 ± 0.097-0.26 ± 0.094
Loss of Weight, Change at Day 7-0.30 ± 0.129-0.36 ± 0.137-0.60 ± 0.135
Loss of Weight, Change at Day 14-0.43 ± 0.150-0.42 ± 0.164-0.64 ± 0.158
Loss of Weight, Change at Day 21-0.49 ± 0.160-0.59 ± 0.177-0.61 ± 0.169
Loss of Weight, Change at Day 30-0.24 ± 0.133-0.55 ± 0.144-0.48 ± 0.143
Insight, Change at Hour 2-0.01 ± 0.0370.02 ± 0.0400.02 ± 0.039
Insight, Change at Hour 4-0.01 ± 0.037-0.01 ± 0.0400.04 ± 0.039
Insight, Change at Hour 8-0.03 ± 0.037-0.04 ± 0.0400.04 ± 0.039
Insight, Change at Hour 12-0.03 ± 0.037-0.06 ± 0.0410.07 ± 0.039
Insight, Change at Hour 240.04 ± 0.038-0.01 ± 0.0400.04 ± 0.039
Insight, Change at Hour 36-0.03 ± 0.037-0.04 ± 0.041-0.01 ± 0.039
Insight, Change at Hour 48-0.03 ± 0.0370.02 ± 0.0400.02 ± 0.039
Insight, Change at Hour 60-0.06 ± 0.037-0.06 ± 0.040-0.09 ± 0.039
Insight, Change at Hour 72-0.06 ± 0.037-0.01 ± 0.040-0.06 ± 0.039
Insight, Change at Day 7-0.06 ± 0.037-0.06 ± 0.040-0.03 ± 0.039
Insight, Change at Day 14-0.03 ± 0.041-0.07 ± 0.045-0.09 ± 0.044
Insight, Change at Day 21-0.10 ± 0.042-0.08 ± 0.047-0.09 ± 0.044
Insight, Change at Day 30-0.01 ± 0.038-0.06 ± 0.041-0.08 ± 0.041
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9681 · Ls mean difference: -0.01 · 95% CI -0.39 to 0.37
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6337 · Ls mean difference: 0.09 · 95% CI -0.28 to 0.46
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4690 · Ls mean difference: -0.17 · 95% CI -0.64 to 0.30
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9905 · Ls mean difference: 0.00 · 95% CI -0.46 to 0.46
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3984 · Ls mean difference: -0.20 · 95% CI -0.68 to 0.27
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7042 · Ls mean difference: 0.09 · 95% CI -0.37 to 0.55
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4941 · Ls mean difference: -0.17 · 95% CI -0.66 to 0.32
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4572 · Ls mean difference: 0.18 · 95% CI -0.30 to 0.65
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9866 · Ls mean difference: 0.00 · 95% CI -0.47 to 0.46
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7490 · Ls mean difference: -0.07 · 95% CI -0.53 to 0.38
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0235 · Ls mean difference: -0.57 · 95% CI -1.06 to -0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9286 · Ls mean difference: -0.02 · 95% CI -0.50 to 0.45
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0544 · Ls mean difference: -0.49 · 95% CI -0.99 to 0.01
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2903 · Ls mean difference: -0.26 · 95% CI -0.74 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0044 · Ls mean difference: -0.71 · 95% CI -1.19 to -0.23
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1339 · Ls mean difference: -0.36 · 95% CI -0.83 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0149 · Ls mean difference: -0.58 · 95% CI -1.04 to -0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3213 · Ls mean difference: -0.23 · 95% CI -0.68 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0703 · Ls mean difference: -0.45 · 95% CI -0.94 to 0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8152 · Ls mean difference: -0.06 · 95% CI -0.53 to 0.42
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0805 · Ls mean difference: -0.53 · 95% CI -1.13 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6964 · Ls mean difference: -0.11 · 95% CI -0.69 to 0.46
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2998 · Ls mean difference: -0.32 · 95% CI -0.92 to 0.29
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3448 · Ls mean difference: -0.28 · 95% CI -0.85 to 0.30
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0089 · Ls mean difference: -0.66 · 95% CI -1.15 to -0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0772 · Ls mean difference: -0.44 · 95% CI -0.92 to 0.05
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6809 · Ls mean difference: -0.08 · 95% CI -0.46 to 0.30
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7297 · Ls mean difference: 0.06 · 95% CI -0.30 to 0.43
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0626 · Ls mean difference: -0.43 · 95% CI -0.87 to 0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5196 · Ls mean difference: -0.14 · 95% CI -0.58 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0772 · Ls mean difference: -0.42 · 95% CI -0.88 to 0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6610 · Ls mean difference: -0.10 · 95% CI -0.55 to 0.35
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4007 · Ls mean difference: -0.20 · 95% CI -0.67 to 0.27
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2292 · Ls mean difference: 0.28 · 95% CI -0.18 to 0.74
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0540 · Ls mean difference: -0.45 · 95% CI -0.92 to 0.01
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9590 · Ls mean difference: 0.01 · 95% CI -0.44 to 0.46
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1048 · Ls mean difference: -0.36 · 95% CI -0.79 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8979 · Ls mean difference: -0.03 · 95% CI -0.44 to 0.39
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0819 · Ls mean difference: -0.38 · 95% CI -0.82 to 0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1099 · Ls mean difference: -0.34 · 95% CI -0.77 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0373 · Ls mean difference: -0.45 · 95% CI -0.88 to -0.03
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0577 · Ls mean difference: -0.40 · 95% CI -0.81 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2023 · Ls mean difference: -0.27 · 95% CI -0.69 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4444 · Ls mean difference: -0.16 · 95% CI -0.56 to 0.25
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3645 · Ls mean difference: -0.20 · 95% CI -0.64 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4035 · Ls mean difference: -0.18 · 95% CI -0.60 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4877 · Ls mean difference: -0.16 · 95% CI -0.62 to 0.30
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3134 · Ls mean difference: -0.23 · 95% CI -0.68 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0922 · Ls mean difference: -0.41 · 95% CI -0.89 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0761 · Ls mean difference: -0.41 · 95% CI -0.87 to 0.04
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3275 · Ls mean difference: -0.21 · 95% CI -0.64 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3041 · Ls mean difference: -0.22 · 95% CI -0.64 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0450 · Ls mean difference: -0.30 · 95% CI -0.59 to -0.01
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5351 · Ls mean difference: 0.09 · 95% CI -0.19 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0525 · Ls men difference: -0.28 · 95% CI -0.56 to 0.00
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7932 · Ls mean difference: 0.04 · 95% CI -0.24 to 0.31
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1300 · Ls mean difference: -0.20 · 95% CI -0.45 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1631 · Ls mean difference: 0.17 · 95% CI -0.07 to 0.42
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.8215 · Ls mean difference: 0.03 · 95% CI -0.23 to 0.29
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0380 · Ls mean difference: 0.26 · 95% CI 0.01 to 0.51
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5070 · Ls mean difference: -0.08 · 95% CI -0.33 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1094 · Ls mean difference: 0.19 · 95% CI -0.04 to 0.43
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3112 · Ls mean difference: -0.10 · 95% CI -0.30 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1345 · Ls mean difference: 0.14 · 95% CI -0.05 to 0.33
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5148 · Ls mean difference: -0.06 · 95% CI -0.24 to 0.12
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3863 · Ls mean difference: -0.08 · 95% CI -0.25 to 0.10
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0209 · Ls mean difference: -0.22 · 95% CI -0.41 to -0.03
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0616 · Ls men difference: -0.17 · 95% CI -0.35 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1860 · Ls mean difference: -0.13 · 95% CI -0.33 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7730 · Ls mean difference: -0.03 · 95% CI -0.22 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1593 · Ls mean difference: -0.18 · 95% CI -0.44 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6371 · Ls mean difference: -0.06 · 95% CI -0.31 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5655 · Ls mean difference: -0.07 · 95% CI -0.32 to 0.18
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3326 · Ls mean difference: 0.12 · 95% CI -0.12 to 0.36
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3577 · Ls mean difference: -0.19 · 95% CI -0.59 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1646 · Ls mean difference: -0.27 · 95% CI -0.66 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0545 · Ls mean difference: -0.23 · 95% CI -0.46 to 0.00
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2903 · Ls mean difference: -0.12 · 95% CI -0.35 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0395 · Ls mean difference: 0.23 · 95% CI 0.01 to 0.45
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4690 · Ls mean difference: 0.08 · 95% CI -0.14 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6066 · Ls difference: 0.07 · 95% CI -0.20 to 0.35
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9737 · Ls mean difference: 0.00 · 95% CI -0.26 to 0.27
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4030 · Ls mean difference: 0.12 · 95% CI -0.17 to 0.42
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6357 · Ls mean difference: -0.07 · 95% CI -0.36 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.8605 · Ls mean difference: -0.02 · 95% CI -0.29 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7534 · Ls mean difference: -0.04 · 95% CI -0.30 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0021 · Ls mean difference: -0.63 · 95% CI -1.03 to -0.23
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0394 · Ls mean difference: -0.41 · 95% CI -0.80 to -0.02
  • Placebo vs SAGE-547 60 μg/kg/h · Wilcoxon (Mann-Whitney) · p = 0.0039 · Ls mean difference: -0.61 · 95% CI -1.03 to -0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1591 · Ls mean difference: -0.29 · 95% CI -0.69 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1402 · Ls mean difference: -0.31 · 95% CI -0.73 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0143 · Ls mean difference: -0.51 · 95% CI -0.91 to -0.10
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2293 · Ls mean difference: -0.25 · 95% CI -0.65 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0884 · Ls mean difference: -0.34 · 95% CI -0.74 to 0.05
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0622 · Ls mean difference: -0.39 · 95% CI -0.80 to 0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0955 · Ls mean difference: -0.34 · 95% CI -0.74 to 0.06
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0173 · Ls mean difference: -0.51 · 95% CI -0.92 to -0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1687 · Ls mean difference: -0.29 · 95% CI -0.69 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · Wilcoxon (Mann-Whitney) · p = 0.3861 · Ls mean difference: -0.22 · 95% CI -0.74 to 0.29
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7060 · Ls mean difference: -0.09 · 95% CI -0.59 to 0.40
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0112 · Ls mean difference: -0.59 · 95% CI -1.05 to -0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0570 · Ls mean difference: -0.42 · 95% CI -0.86 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0018 · Ls mean difference: -0.67 · 95% CI -1.08 to -0.26
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0443 · Ls mean difference: -0.42 · 95% CI -0.83 to -0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1197 · Ls mean difference: 0.16 · 95% CI -0.04 to 0.37
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7171 · Ls mean difference: -0.04 · 95% CI -0.24 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7151 · Ls mean difference: -0.05 · 95% CI -0.32 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5210 · Ls mean difference: -0.09 · 95% CI -0.35 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7332 · Ls mean difference: 0.05 · 95% CI -0.23 to 0.33
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4163 · Ls mean difference: -0.11 · 95% CI -0.39 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.8625 · Ls mean difference: -0.02 · 95% CI -0.28 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6196 · Ls mean difference: -0.06 · 95% CI -0.32 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0373 · Ls mean difference: -0.41 · 95% CI -0.80 to -0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0644 · Ls mean difference: -0.36 · 95% CI -0.74 to 0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1347 · Ls mean difference: -0.29 · 95% CI -0.66 to 0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1269 · Ls mean difference: -0.28 · 95% CI -0.65 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1650 · Ls mean difference: -0.27 · 95% CI -0.65 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1291 · Ls mean difference: -0.29 · 95% CI -0.66 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0402 · Ls mean difference: -0.39 · 95% CI -0.77 to -0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0342 · Ls mean difference: -0.40 · 95% CI -0.76 to -0.03
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1269 · Ls mean difference: -0.30 · 95% CI -0.68 to 0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3945 · Ls mean difference: -0.16 · 95% CI -0.53 to 0.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5828 · Ls mean difference: -0.10 · 95% CI -0.47 to 0.26
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6625 · Ls mean difference: 0.08 · 95% CI -0.28 to 0.44
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0041 · Ls mean difference: -0.64 · 95% CI -1.07 to -0.21
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2222 · Ls mean difference: -0.26 · 95% CI -0.67 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0245 · Ls mean difference: -0.50 · 95% CI -0.93 to -0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5119 · Ls mean difference: -0.14 · 95% CI -0.55 to 0.28
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0299 · Ls mean difference: -0.43 · 95% CI -0.82 to -0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2824 · Ls mean difference: -0.21 · 95% CI -0.60 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1768 · Ls mean difference: 0.18 · 95% CI -0.08 to 0.43
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6498 · Ls mean difference: -0.06 · 95% CI -0.31 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7689 · Ls mean difference: 0.04 · 95% CI -0.25 to 0.34
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2236 · Ls mean difference: -0.18 · 95% CI -0.47 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6952 · Ls mean difference: -0.06 · 95% CI -0.35 to 0.23
  • Placebo · MMRM · p = 0.1184 · Ls mean difference: -0.23 · 95% CI -0.51 to 0.06
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3031 · Ls mean difference: 0.15 · 95% CI -0.14 to 0.45
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3091 · Ls mean difference: -0.15 · 95% CI -0.44 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1525 · Ls mean difference: -0.26 · 95% CI -0.61 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1214 · Ls mean difference: -0.27 · 95% CI -0.62 to 0.07
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3811 · Ls mean difference: -0.16 · 95% CI -0.53 to 0.21
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3851 · Ls mean difference: -0.16 · 95% CI -0.51 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1373 · Ls mean difference: -0.27 · 95% CI -0.63 to 0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1360 · Ls mean difference: -0.27 · 95% CI -0.62 to 0.09
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1264 · Ls mean difference: -0.27 · 95% CI -0.62 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0567 · Ls mean difference: -0.33 · 95% CI -0.67 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7447 · Ls mean difference: -0.06 · 95% CI -0.41 to 0.29
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7727 · Ls mean difference: -0.05 · 95% CI -0.39 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6590 · Ls mean difference: 0.08 · 95% CI -0.28 to 0.44
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3951 · Ls mean difference: -0.15 · 95% CI -0.51 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4576 · Ls mean difference: -0.17 · 95% CI -0.63 to 0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7609 · Ls mean difference: -0.07 · 95% CI -0.51 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6220 · Ls mean difference: -0.12 · 95% CI -0.58 to 0.35
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9081 · Ls mean difference: 0.03 · 95% CI -0.42 to 0.47
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1668 · Ls mean difference: -0.27 · 95% CI -0.65 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0935 · Ls mean difference: -0.32 · 95% CI -0.69 to 0.05
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4038 · Ls mean difference: -0.13 · 95% CI -0.42 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7559 · Ls mean difference: 0.05 · 95% CI -0.24 to 0.33
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2006 · Ls mean difference: -0.23 · 95% CI -0.59 to 0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6334 · Ls mean difference: 0.08 · 95% CI -0.26 to 0.43
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5431 · Ls mean difference: -0.14 · 95% CI -0.60 to 0.32
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5278 · Ls mean difference: 0.14 · 95% CI -0.30 to 0.59
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4312 · Ls mean difference: -0.18 · 95% CI -0.64 to 0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3947 · Ls mean difference: 0.19 · 95% CI -0.25 to 0.64
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6081 · Ls mean difference: -0.13 · 95% CI -0.61 to 0.36
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8949 · Ls mean difference: 0.03 · 95% CI -0.44 to 0.50
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1120 · Ls mean difference: -0.38 · 95% CI -0.84 to 0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1842 · Ls mean difference: 0.30 · 95% CI -0.15 to 0.76
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2646 · Ls mean difference: -0.29 · 95% CI -0.81 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8101 · Ls mean difference: -0.06 · 95% CI -0.56 to 0.44
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0215 · Ls mean difference: -0.58 · 95% CI -1.07 to -0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3226 · Ls mean difference: -0.24 · 95% CI -0.72 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0339 · Ls mean difference: -0.51 · 95% CI -0.98 to -0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9824 · Ls mean difference: 0.01 · 95% CI -0.46 to 0.47
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0950 · Ls mean difference: -0.43 · 95% CI -0.93 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4865 · Ls mean difference: -0.17 · 95% CI -0.67 to 0.32
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9861 · Ls mean difference: 0.01 · 95% CI -0.57 to 0.58
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9266 · Ls mean difference: -0.03 · 95% CI -0.59 to 0.54
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0360 · Ls mean difference: -0.61 · 95% CI -1.17 to -0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0583 · Ls mean difference: -0.52 · 95% CI -1.06 to 0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0404 · Ls mean difference: -0.53 · 95% CI -1.03 to -0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1352 · Ls mean difference: -0.37 · 95% CI -0.87 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0056 · Ls mean difference: 0.34 · 95% CI 0.10 to 0.58
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1537 · Ls mean difference: 0.17 · 95% CI -0.06 to 0.40
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0142 · Ls mean difference: 0.32 · 95% CI 0.07 to 0.58
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0159 · Ls mean difference: 0.31 · 95% CI 0.06 to 0.56
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2255 · Ls mean difference: 0.16 · 95% CI -0.10 to 0.42
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1069 · Ls mean difference: 0.21 · 95% CI -0.05 to 0.46
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4932 · Ls mean difference: 0.10 · 95% CI -0.19 to 0.39
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2634 · Ls mean difference: 0.16 · 95% CI -0.12 to 0.43
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9284 · Ls mean difference: 0.01 · 95% CI -0.25 to 0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9459 · Ls mean difference: 0.01 · 95% CI -0.25 to 0.26
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2908 · Ls mean difference: -0.16 · 95% CI -0.46 to 0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6834 · Ls mean difference: 0.06 · 95% CI -0.23 to 0.35
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3579 · Ls mean difference: -0.13 · 95% CI -0.41 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8270 · Ls mean difference: -0.03 · 95% CI -0.30 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5292 · Ls mean difference: -0.08 · 95% CI -0.34 to 0.18
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8790 · Ls mean difference: 0.02 · 95% CI -0.23 to 0.27
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1347 · Ls mean difference: -0.20 · 95% CI -0.46 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2874 · Ls mean difference: -0.14 · 95% CI -0.40 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0086 · Ls mean difference: -0.35 · 95% CI -0.61 to -0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7864 · Ls mean difference: -0.03 · 95% CI -0.29 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4383 · Ls mean difference: -0.13 · 95% CI -0.48 to 0.21
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8767 · Ls mean difference: -0.03 · 95% CI -0.36 to 0.31
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0341 · Ls mean difference: -0.33 · 95% CI -0.63 to -0.03
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5629 · Ls mean difference: -0.09 · 95% CI -0.38 to 0.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0016 · Ls mean difference: -0.42 · 95% CI -0.67 to -0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0495 · Ls mean difference: -0.25 · 95% CI -0.50 to 0.00
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7177 · Ls mean difference: -0.06 · 95% CI -0.36 to 0.25
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9401 · Ls mean difference: 0.01 · 95% CI -0.29 to 0.31
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3201 · Ls mean difference: -0.15 · 95% CI -0.44 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8286 · Ls mean difference: 0.03 · 95% CI -0.25 to 0.32
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3022 · Ls mean difference: -0.17 · 95% CI -0.49 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8022 · Ls mean difference: -0.04 · 95% CI -0.35 to 0.27
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5665 · Ls mean difference: -0.10 · 95% CI -0.42 to 0.23
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8170 · Ls mean difference: -0.04 · 95% CI -0.36 to 0.28
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0404 · Ls mean difference: -0.32 · 95% CI -0.63 to -0.01
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3128 · Ls mean difference: -0.15 · 95% CI -0.45 to 0.15
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2400 · Ls mean difference: -0.19 · 95% CI -0.51 to 0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4840 · Ls mean difference: -0.11 · 95% CI -0.42 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7768 · Ls mean difference: -0.04 · 95% CI -0.32 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7713 · Ls mean difference: -0.04 · 95% CI -0.31 to 0.23
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0716 · Ls mean difference: -0.28 · 95% CI -0.58 to 0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4317 · Ls mean difference: -0.12 · 95% CI -0.41 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2115 · Ls mean difference: -0.20 · 95% CI -0.52 to 0.12
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2818 · Ls mean difference: -0.17 · 95% CI -0.48 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2018 · Ls mean difference: -0.18 · 95% CI -0.46 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6554 · Ls mean difference: -0.06 · 95% CI -0.33 to 0.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4754 · Ls mean difference: 0.12 · 95% CI -0.21 to 0.46
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7776 · Ls mean difference: 0.05 · 95% CI -0.28 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7172 · Ls mean difference: -0.08 · 95% CI -0.50 to 0.35
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4791 · Ls mean difference: -0.14 · 95% CI -0.55 to 0.26
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3562 · Ls mean difference: -0.15 · 95% CI -0.48 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8859 · Ls mean difference: 0.02 · 95% CI -0.30 to 0.34
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5888 · Ls mean difference: -0.10 · 95% CI -0.49 to 0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3992 · Ls mean difference: -0.16 · 95% CI -0.53 to 0.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1212 · Ls mean difference: -0.35 · 95% CI -0.80 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3185 · Ls mean difference: -0.22 · 95% CI -0.66 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4809 · Ls mean difference: -0.16 · 95% CI -0.62 to 0.29
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8953 · Ls mean difference: 0.03 · 95% CI -0.42 to 0.48
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5616 · Ls mean difference: -0.13 · 95% CI -0.57 to 0.31
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8571 · Ls mean difference: 0.04 · 95% CI -0.39 to 0.47
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0037 · Ls mean difference: -0.63 · 95% CI -1.05 to -0.21
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0386 · Ls mean difference: -0.43 · 95% CI -0.84 to -0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0044 · Ls mean difference: -0.63 · 95% CI -1.05 to -0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8308 · Ls mean difference: -0.04 · 95% CI -0.46 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0388 · Ls mean difference: -0.45 · 95% CI -0.87 to -0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1622 · Ls mean difference: -0.29 · 95% CI -0.71 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0179 · Ls mean difference: -0.49 · 95% CI -0.89 to -0.09
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4283 · Ls mean difference: -0.16 · 95% CI -0.55 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1899 · Ls mean difference: -0.29 · 95% CI -0.72 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8022 · Ls mean difference: -0.05 · 95% CI -0.48 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3780 · Ls mean difference: -0.19 · 95% CI -0.62 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8110 · Ls mean difference: -0.05 · 95% CI -0.47 to 0.36
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.8908 · Ls mean difference: -0.04 · 95% CI -0.58 to 0.50
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3596 · Ls mean difference: 0.24 · 95% CI -0.28 to 0.76
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7617 · Ls mean difference: -0.09 · 95% CI -0.67 to 0.49
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5498 · Ls mean difference: -0.17 · 95% CI -0.73 to 0.39
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2066 · Ls mean difference: -0.30 · 95% CI -0.76 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2321 · Ls mean difference: -0.28 · 95% CI -0.73 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5582 · Ls mean difference: -0.11 · 95% CI -0.49 to 0.27
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2945 · Ls mean difference: -0.20 · 95% CI -0.56 to 0.17
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2684 · Ls mean difference: -0.23 · 95% CI -0.64 to 0.18
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9396 · Ls mean difference: -0.02 · 95% CI -0.42 to 0.39
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0283 · Ls mean difference: -0.43 · 95% CI -0.82 to -0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1794 · Ls mean difference: -0.26 · 95% CI -0.63 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1091 · Ls mean difference: -0.30 · 95% CI -0.68 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7921 · Ls mean difference: -0.05 · 95% CI -0.41 to 0.31
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0055 · Ls mean difference: -0.47 · 95% CI -0.80 to -0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0300 · Ls mean difference: -0.35 · 95% CI -0.67 to -0.03
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0118 · Ls mean difference: -0.47 · 95% CI -0.84 to -0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2266 · Ls mean difference: -0.22 · 95% CI -0.57 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0025 · Ls mean difference: -0.56 · 95% CI -0.92 to -0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0555 · Ls mean difference: -0.34 · 95% CI -0.69 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0013 · Ls mean difference: -0.58 · 95% CI -0.93 to -0.23
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0775 · Ls mean difference: -0.31 · 95% CI -0.64 to 0.03
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0006 · Ls mean difference: -0.67 · 95% CI -1.05 to -0.30
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0415 · Ls mean difference: -0.38 · 95% CI -0.75 to -0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0581 · Ls mean difference: -0.37 · 95% CI -0.75 to 0.01
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6826 · Ls mean difference: -0.08 · 95% CI -0.45 to 0.30
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0912 · Ls mean difference: -0.38 · 95% CI -0.83 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3988 · Ls mean difference: -0.19 · 95% CI -0.62 to 0.25
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0504 · Ls mean difference: -0.46 · 95% CI -0.91 to 0.00
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6019 · Ls mean difference: -0.12 · 95% CI -0.55 to 0.32
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0070 · Ls mean difference: -0.61 · 95% CI -1.05 to -0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3785 · Ls mean difference: -0.19 · 95% CI -0.62 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9609 · Ls mean difference: -0.01 · 95% CI -0.32 to 0.31
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9183 · Ls mean difference: -0.02 · 95% CI -0.32 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0710 · Ls mean difference: -0.27 · 95% CI -0.57 to 0.02
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2607 · Ls mean difference: -0.16 · 95% CI -0.45 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2466 · Ls mean difference: -0.18 · 95% CI -0.50 to 0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3461 · Ls mean difference: -0.14 · 95% CI -0.45 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0919 · Ls mean difference: -0.28 · 95% CI -0.60 to 0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7554 · Ls mean difference: -0.05 · 95% CI -0.36 to 0.26
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0150 · Ls mean difference: -0.41 · 95% CI -0.74 to -0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0482 · Ls mean difference: -0.32 · 95% CI -0.64 to 0.00
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0003 · Ls mean difference: -0.61 · 95% CI -0.93 to -0.28
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1182 · Ls mean difference: -0.25 · 95% CI -0.56 to 0.06
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0008 · Ls mean difference: -0.55 · 95% CI -0.87 to -0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1379 · Ls mean difference: -0.23 · 95% CI -0.54 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0040 · Ls mean difference: -0.43 · 95% CI -0.71 to -0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3100 · Ls mean difference: -0.14 · 95% CI -0.42 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0003 · Ls mean difference: -0.56 · 95% CI -0.85 to -0.26
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0223 · Ls mean difference: -0.33 · 95% CI -0.61 to -0.05
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0276 · Ls mean difference: -0.37 · 95% CI -0.70 to -0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8516 · Ls mean difference: -0.03 · 95% CI -0.35 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1669 · Ls mean difference: -0.26 · 95% CI -0.63 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4935 · Ls mean difference: -0.12 · 95% CI -0.48 to 0.23
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0202 · Ls mean difference: -0.47 · 95% CI -0.86 to -0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2683 · Ls mean difference: -0.21 · 95% CI -0.58 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0531 · Ls mean difference: -0.32 · 95% CI -0.65 to 0.00
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5609 · Ls mean difference: -0.09 · 95% CI -0.41 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6779 · Ls mean difference: -0.05 · 95% CI -0.30 to 0.19
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4559 · Ls mean difference: 0.09 · 95% CI -0.15 to 0.32
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2254 · Ls mean difference: -0.16 · 95% CI -0.43 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6437 · Ls mean difference: -0.06 · 95% CI -0.32 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6678 · Ls mean difference: -0.06 · 95% CI -0.32 to 0.21
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9321 · Ls mean difference: -0.01 · 95% CI -0.27 to 0.24
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9778 · Ls mean difference: 0.00 · 95% CI -0.31 to 0.32
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9307 · Ls mean difference: 0.01 · 95% CI -0.29 to 0.31
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6791 · Ls mean difference: -0.07 · 95% CI -0.41 to 0.27
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7769 · Ls mean difference: 0.05 · 95% CI -0.28 to 0.38
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7206 · Ls mean difference: -0.06 · 95% CI -0.38 to 0.26
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3549 · Ls mean difference: -0.15 · 95% CI -0.45 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0231 · Ls mean difference: -0.38 · 95% CI -0.70 to -0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1450 · Ls mean difference: -0.23 · 95% CI -0.55 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0855 · Ls mean difference: -0.28 · 95% CI -0.60 to 0.04
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3068 · Ls mean difference: -0.16 · 95% CI -0.47 to 0.15
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0069 · Ls mean difference: -0.45 · 95% CI -0.77 to -0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2174 · Ls mean difference: -0.20 · 95% CI -0.51 to 0.12
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1020 · Ls mean difference: -0.29 · 95% CI -0.63 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9587 · Ls mean difference: 0.01 · 95% CI -0.33 to 0.35
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1690 · Ls mean difference: -0.28 · 95% CI -0.69 to 0.12
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7919 · Ls mean difference: 0.05 · 95% CI -0.34 to 0.44
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0192 · Ls mean difference: -0.49 · 95% CI -0.89 to -0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3887 · Ls mean difference: -0.17 · 95% CI -0.56 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0719 · Ls mean difference: -0.34 · 95% CI -0.72 to 0.03
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1195 · Ls mean difference: -0.29 · 95% CI -0.66 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9552 · Ls mean difference: 0.00 · 95% CI -0.16 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0384 · Ls mean difference: -0.16 · 95% CI -0.31 to -0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2582 · Ls mean difference: -0.11 · 95% CI -0.30 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1511 · Ls mean difference: -0.14 · 95% CI -0.32 to 0.05
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4631 · Ls mean difference: -0.09 · 95% CI -0.34 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4628 · Ls mean difference: -0.09 · 95% CI -0.33 to 0.15
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9005 · Ls mean difference: -0.01 · 95% CI -0.23 to 0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1121 · Ls mean difference: -0.17 · 95% CI -0.38 to 0.04
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4167 · Ls mean difference: -0.12 · 95% CI -0.40 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4071 · Ls mean difference: -0.12 · 95% CI -0.40 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1278 · Ls mean difference: -0.23 · 95% CI -0.53 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0573 · Ls mean difference: -0.28 · 95% CI -0.57 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4842 · Ls mean difference: -0.11 · 95% CI -0.42 to 0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0692 · Ls mean difference: -0.28 · 95% CI -0.58 to 0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4028 · Ls mean difference: -0.13 · 95% CI -0.44 to 0.18
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0354 · Ls mean difference: -0.33 · 95% CI -0.63 to -0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1228 · Ls mean difference: -0.24 · 95% CI -0.55 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0099 · Ls mean difference: -0.40 · 95% CI -0.70 to -0.10
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2174 · Ls mean difference: -0.20 · 95% CI -0.53 to 0.12
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0820 · Ls mean difference: -0.28 · 95% CI -0.60 to 0.04
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2642 · Ls mean difference: -0.22 · 95% CI -0.60 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0718 · Ls mean difference: -0.34 · 95% CI -0.72 to 0.03
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3055 · Ls mean difference: -0.22 · 95% CI -0.64 to 0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3533 · Ls mean difference: -0.19 · 95% CI -0.59 to 0.21
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4514 · Ls mean difference: -0.15 · 95% CI -0.53 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4907 · Ls mean difference: -0.13 · 95% CI -0.51 to 0.25
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6949 · Ls mean difference: -0.06 · 95% CI -0.36 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4670 · Ls mean difference: -0.11 · 95% CI -0.40 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6556 · Ls mean difference: -0.07 · 95% CI -0.39 to 0.25
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9272 · Ls mean difference: -0.01 · 95% CI -0.32 to 0.29
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1395 · Ls mean difference: -0.24 · 95% CI -0.57 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2601 · Ls mean difference: -0.18 · 95% CI -0.50 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5626 · Ls mean difference: -0.09 · 95% CI -0.40 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4622 · Ls mean difference: -0.11 · 95% CI -0.42 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2858 · Ls mean difference: -0.16 · 95% CI -0.46 to 0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5369 · Ls mean difference: -0.09 · 95% CI -0.38 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1510 · Ls mean difference: -0.22 · 95% CI -0.52 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5107 · Ls mean difference: -0.10 · 95% CI -0.38 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3301 · Ls mean difference: -0.15 · 95% CI -0.45 to 0.15
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5139 · Ls mean difference: -0.10 · 95% CI -0.39 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4073 · Ls mean difference: -0.12 · 95% CI -0.40 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4649 · Ls mean difference: -0.10 · 95% CI -0.38 to 0.17
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6926 · Ls mean difference: -0.06 · 95% CI -0.34 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7260 · Ls mean difference: 0.05 · 95% CI -0.22 to 0.32
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1486 · Ls mean difference: -0.20 · 95% CI -0.47 to 0.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4800 · Ls mean difference: -0.09 · 95% CI -0.36 to 0.17
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7792 · Ls mean difference: -0.05 · 95% CI -0.40 to 0.30
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8644 · Ls mean difference: 0.03 · 95% CI -0.31 to 0.37
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7994 · Ls mean difference: 0.04 · 95% CI -0.27 to 0.35
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0811 · Ls mean difference: 0.27 · 95% CI -0.03 to 0.57
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6978 · Ls mean difference: -0.06 · 95% CI -0.34 to 0.23
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9749 · Ls mean difference: 0.00 · 95% CI -0.28 to 0.28
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3158 · Ls mean difference: 0.08 · 95% CI -0.08 to 0.24
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1901 · Ls mean difference: 0.10 · 95% CI -0.05 to 0.26
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7229 · Ls mean difference: 0.03 · 95% CI -0.12 to 0.17
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2715 · Ls mean difference: 0.08 · 95% CI -0.06 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5421 · Ls mean difference: 0.05 · 95% CI -0.12 to 0.22
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.7215 · Ls mean difference: 0.03 · 95% CI -0.14 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2246 · Ls mean difference: 0.12 · 95% CI -0.07 to 0.31
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9671 · Ls mean difference: 0.00 · 95% CI -0.19 to 0.19
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6527 · Ls mean difference: -0.05 · 95% CI -0.29 to 0.19
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1647 · Ls mean difference: -0.17 · 95% CI -0.40 to 0.07
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7093 · Ls mean difference: 0.04 · 95% CI -0.18 to 0.26
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6333 · Ls mean difference: -0.05 · 95% CI -0.26 to 0.16
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5238 · Ls mean difference: -0.08 · 95% CI -0.31 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0782 · Ls mean difference: -0.21 · 95% CI -0.44 to 0.02
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2346 · Ls mean difference: -0.16 · 95% CI -0.44 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0631 · Ls mean difference: -0.25 · 95% CI -0.52 to 0.01
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6274 · Ls mean difference: -0.06 · 95% CI -0.32 to 0.20
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3589 · Ls mean difference: -0.12 · 95% CI -0.37 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7604 · Ls mean difference: -0.06 · 95% CI -0.43 to 0.31
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1106 · Ls mean difference: -0.30 · 95% CI -0.66 to 0.07
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9776 · Ls mean difference: 0.01 · 95% CI -0.43 to 0.45
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3239 · Ls mean difference: -0.21 · 95% CI -0.65 to 0.22
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6736 · Ls mean difference: -0.10 · 95% CI -0.57 to 0.37
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6136 · Ls mean difference: -0.12 · 95% CI -0.58 to 0.34
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1141 · Ls mean difference: -0.31 · 95% CI -0.70 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.2185 · Ls mean difference: -0.24 · 95% CI -0.62 to 0.14
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.6191 · Ls mean difference: 0.03 · 95% CI -0.08 to 0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6169 · Ls mean difference: 0.03 · 95% CI -0.08 to 0.13
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9911 · Ls mean difference: 0.00 · 95% CI -0.11 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3360 · Ls mean difference: 0.05 · 95% CI -0.05 to 0.15
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9638 · Ls mean difference: 0.00 · 95% CI -0.11 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1610 · Ls mean difference: 0.07 · 95% CI -0.03 to 0.18
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.5763 · Ls mean difference: -0.03 · 95% CI -0.14 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0599 · Ls mean difference: 0.10 · 95% CI 0.00 to 0.20
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3916 · Ls mean difference: -0.05 · 95% CI -0.15 to 0.06
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9602 · Ls mean difference: 0.00 · 95% CI -0.10 to 0.11
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9676 · Ls mean difference: 0.00 · 95% CI -0.11 to 0.11
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6397 · Ls mean difference: 0.02 · 95% CI -0.08 to 0.13
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3400 · Ls mean difference: 0.05 · 95% CI -0.05 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3472 · Ls mean difference: 0.05 · 95% CI -0.05 to 0.15
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9160 · Ls mean difference: -0.01 · 95% CI -0.11 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.5948 · Ls mean difference: -0.03 · 95% CI -0.13 to 0.08
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.3755 · Ls mean difference: 0.05 · 95% CI -0.06 to 0.16
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9752 · Ls mean difference: 0.00 · 95% CI -0.11 to 0.10
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9188 · Ls mean difference: -0.01 · 95% CI -0.11 to 0.10
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6379 · Ls mean difference: 0.02 · 95% CI -0.08 to 0.13
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4967 · Ls mean difference: -0.04 · 95% CI -0.16 to 0.08
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3492 · Ls mean difference: -0.06 · 95% CI -0.17 to 0.06
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7136 · Ls mean difference: 0.02 · 95% CI -0.10 to 0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8163 · Ls mean difference: 0.01 · 95% CI -0.10 to 0.13
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.2825 · Ls mean difference: -0.06 · 95% CI -0.17 to 0.05
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1603 · Ls mean difference: -0.08 · 95% CI -0.18 to 0.03
SecondaryChange From Baseline at Key Time Points in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score

The MADRS is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes in participants with mood disorders. It was designed as an adjunct to the HAM-D, to be more sensitive than the Hamilton Scale to the changes brought on by antidepressants and other forms of treatment. Each item yielded a score of 0 to 6. The MADRS total score was calculated as the sum of the 10 individual item scores, which ranged from 0 to 60. Higher MADRS scores indicates more severe depression. A negative change from baseline indicates less severe depression. A positive change from baseline indicates more severe depression.

Time frame:
Baseline, Hour 60, Days 7 and 30
Reported as:
Least squares mean · score on a scale
Change From Baseline at Key Time Points in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 60-19.98 ± 1.688-26.84 ± 1.822-24.19 ± 1.797
Day 7-19.01 ± 1.865-23.31 ± 2.001-20.32 ± 1.982
Day 30-19.43 ± 1.917-25.06 ± 2.091-23.02 ± 2.080
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0054 · Ls mean difference: -6.85 · 95% CI -11.64 to -2.07
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.0763 · Ls mean difference: -4.20 · 95% CI -8.86 to 0.45
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1101 · Ls mean difference: -4.30 · 95% CI -9.60 to 0.99
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6167 · Ls mean difference: -1.31 · 95% CI -6.50 to 3.87
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0447 · Ls mean difference: -5.64 · 95% CI -11.14 to -0.14
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.1908 · Ls mean difference: -3.59 · 95% CI -8.99 to 1.81
SecondaryPercentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response

The CGI-I item employs a 7-point Likert scale to measure the overall improvement in the participant's condition post-treatment. The investigator rated the participant's total improvement whether or not it was due entirely to drug treatment. Response choices include: 0 = not assessed, 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much worse, and 7 = very much worse. The CGI-I was only rated at post-treatment assessments. By definition, all CGI-I assessments were evaluated against baseline conditions. CGI-I response was defined as having a score of 1 (very much improved) or 2 (much improved).

Time frame:
Hour 60, Days 7 and 30
Reported as:
Number · percentage of participants
Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response
percentage of participantsPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 6055.883.882.1
Day 746.571.164.1
Day 3052.480.072.2
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0131 · Odds ratio (or): 4.0 · 95% CI 1.3 to 11.7
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0095 · Odds ratio (or): 4.0 · 95% CI 1.4 to 11.6
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0323 · Odds ratio (or): 2.9 · 95% CI 1.1 to 7.5
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0931 · Odds ratio (or): 2.2 · 95% CI 0.9 to 5.3
  • Placebo vs SAGE-547 60 μg/kg/h · GEE method · p = 0.0139 · Odds ratio (or): 3.6 · 95% CI 1.3 to 10.0
  • Placebo vs SAGE-547 90 μg/kg/h · GEE method · p = 0.0460 · Odds ratio (or): 2.6 · 95% CI 1.0 to 6.9
SecondaryChange From Baseline in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) Total Score

The GAD-7 is a participant-rated, generalized anxiety symptom severity scale. Scoring for GAD-7 generalized anxiety is calculated by assigning scores of 0 = "not at all sure," 1 = "several days," 2 = "over half the days," and 3 = "nearly every day" to the response categories. The GAD-7 total score for the seven items ranges from 0 to 21, where a score of 0 to 4 = minimal anxiety, 5 to 9 = mild anxiety, 10 to 14 = moderate anxiety, and 15 to 21 = severe anxiety. The GAD-7 total score was calculated as the sum of the seven individual item scores. A negative change from baseline indicates less anxiety. A positive change from baseline indicates more anxiety.

Time frame:
Baseline, Hour 60, Days 7, 14, 21 and 30
Reported as:
Least squares mean · score on a scale
Change From Baseline in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) Total Score
score on a scalePlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Hour 60-6.95 ± 1.012-8.08 ± 1.095-7.99 ± 1.087
Day 7-6.57 ± 0.947-9.13 ± 1.025-6.32 ± 1.034
Day 14-8.60 ± 1.081-9.20 ± 1.210-8.71 ± 1.191
Day 21-8.47 ± 1.093-8.53 ± 1.224-9.22 ± 1.199
Day 30-7.70 ± 1.023-9.72 ± 1.129-9.15 ± 1.135
Statistical analysis
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.4389 · Ls mean difference: -1.13 · 95% CI -4.01 to 1.75
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.4645 · Ls mean difference: -1.05 · 95% CI -3.88 to 1.78
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.0622 · Ls mean difference: -2.56 · 95% CI -5.24 to 0.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.8495 · Ls mean difference: 0.25 · 95% CI -2.40 to 2.91
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.7063 · Ls mean difference: -0.60 · 95% CI -3.75 to 2.55
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.9434 · Ls mean difference: -0.11 · 95% CI -3.19 to 2.97
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.9701 · Ls mean difference: -0.06 · 95% CI -3.25 to 3.13
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.6307 · Ls mean difference: -0.76 · 95% CI -3.86 to 2.35
  • Placebo vs SAGE-547 60 μg/kg/h · MMRM · p = 0.1767 · Ls mean difference: -2.02 · 95% CI -4.97 to 0.93
  • Placebo vs SAGE-547 90 μg/kg/h · MMRM · p = 0.3236 · Ls mean difference: -1.46 · 95% CI -4.37 to 1.45
SecondaryPercentage of Participants With Treatment-Emergent Adverse Events

An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (eg, a clinically significant abnormal laboratory finding), symptom, or disease temporally associated with the use of a drug, whether or not it is considered related to the drug. A treatment-emergent AE (TEAE) is defined as an AE with onset on or after the start of study drug infusion, or any worsening of a pre-existing medical condition/AE with onset on or after the start of study drug infusion.

Time frame:
Up to approximately 37 days.
Reported as:
Number · percentage of participants
Percentage of Participants With Treatment-Emergent Adverse Events
percentage of participantsPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Percentage of Participants With Treatment-Emergent Adverse Events51.250.053.7
SecondaryTime to Change in Antidepressant Medication

The time to first start or increase in the dose and time to first stop or decrease in the dose of any antidepressant medication.

Time frame:
Up to approximately 37 days.
Reported as:
Median · days
Time to Change in Antidepressant Medication
daysPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Time to first start/increase in dose16 (5 to 22)12 (5 to 34)8 (4 to 29)
Time to first stop/decrease in dose—29 (29 to 29)19 (19 to 19)

Adverse events

Collected over Up to approximately 37 days.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Placebo0/43 (0%)0/43 (0%)9/43 (20.9%)
SAGE-547 60 μg/kg/h0/38 (0%)1/38 (2.6%)17/38 (44.7%)
SAGE-547 90 μg/kg/h0/41 (0%)0/41 (0%)13/41 (31.7%)
Most frequent serious events
Most frequent serious events
EventPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
Intentional overdoseInjury, poisoning and procedural complications0/431/380/41
Suicidal ideationPsychiatric disorders0/431/380/41
Most frequent other events
Most frequent other events
EventPlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/h
HeadacheNervous system disorders7/437/386/41
SomnolenceNervous system disorders3/437/382/41
DizzinessNervous system disorders1/436/386/41
Dry mouthGastrointestinal disorders0/434/380/41
Infusion site painGeneral disorders1/431/384/41
NauseaGastrointestinal disorders3/431/380/41
Loss of consciousnessNervous system disorders0/432/381/41
FlushingVascular disorders0/432/380/41

Baseline characteristics

All randomized participants who started study drug infusion, had a valid baseline HAM-D assessment and at least one post-baseline HAM-D assessment.

Age, Continuous
Age, Continuous(years)PlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/hTotal
Mean27.2 ± 6.1327.7 ± 6.4627.5 ± 6.0527.4 ± 6.16
Sex: Female, Male
Sex: Female, Male(Participants)PlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/hTotal
Female433841122
Male0000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)PlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/hTotal
American Indian or Alaska Native1001
Asian0011
Black or African American1512835
Native Hawaiian & Other Pacific Islander0011
White27252981
Other0123
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)PlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/hTotal
Hispanic or Latina73717
Not Hispanic or Latina363534105
Hamilton Rating Scale for Depression (HAM-D) Total Score
Hamilton Rating Scale for Depression (HAM-D) Total Score(score on a scale)PlaceboSAGE-547 60 μg/kg/hSAGE-547 90 μg/kg/hTotal
Mean28.6 ± 2.5429.0 ± 2.7028.4 ± 2.4728.7 ± 2.55
08

Study locations

32 sites
  • Sage Investigational Site
    Chandler, Arizona 85226, United States
  • Sage Investigational Site
    Rogers, Arkansas 72758, United States
  • Sage Investigational Site
    Lemon Grove, California 91945, United States
  • Sage Investigational Site
    Orange, California 92868, United States
  • Sage Investigational Site
    Ventura, California 93003, United States
  • Sage Investigational Site
    Gainesville, Florida 32607, United States
  • Sage Investigational Site
    Miami, Florida 33147, United States
  • Sage Investigational Site
    Miramar, Florida 33027, United States
  • Sage Investigational Site
    Orlando, Florida 32807, United States
  • Sage Investigational Site
    Pensacola, Florida 32502, United States
  • Sage Investigational Site
    Pinellas Park, Florida 33782, United States
  • Sage Investigational Site
    Atlanta, Georgia 30331, United States
  • Sage Investigational Site
    Hoffman Estates, Illinois 60169, United States
  • Sage Investigational Site
    Wichita, Kansas 67226, United States
  • Sage Investigational Site
    Edgewood, Kentucky 41017, United States
  • Sage Investigational Site
    Owensboro, Kentucky 42303, United States
  • Sage Investigational Site
    Boston, Massachusetts 02114, United States
  • Sage Investigational Site
    Boston, Massachusetts 02115, United States
  • Sage Investigational Site
    Flowood, Mississippi 39232, United States
  • Sage Investigational Site
    Marlton, New Jersey 08053, United States
  • Sage Investigational Site
    Glen Oaks, New York 11004, United States
  • Sage Investigational Site
    Chapel Hill, North Carolina 27514, United States
  • Sage Investigational Site
    Charlotte, North Carolina 28211, United States
  • Sage Investigational Site
    Raleigh, North Carolina 27612, United States
  • Sage Investigational Site
    Columbus, Ohio 43210, United States
  • Sage Investigational Site
    Dayton, Ohio 45417, United States
  • Sage Investigational Site
    Philadelphia, Pennsylvania 19104, United States
  • Sage Investigational Site
    Houston, Texas 77030, United States
  • Sage Investigational Site
    Houston, Texas 77058, United States
  • Sage Investigational Site
    Richardson, Texas 75080, United States
  • Sage Investigational Site
    San Antonio, Texas 78229, United States
  • Sage Investigational Site
    Orem, Utah 84058, United States
09

References and documents

Publications

  • Gerbasi ME, Meltzer-Brody S, Acaster S, Fridman M, Bonthapally V, Hodgkins P, Kanes SJ, Eldar-Lissai A. Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making. J Womens Health (Larchmt). 2021 Mar;30(3):385-392. doi: 10.1089/jwh.2020.8483. Epub 2020 Nov 12. PubMed 33181049 ↗
  • Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018 Sep 22;392(10152):1058-1070. doi: 10.1016/S0140-6736(18)31551-4. Epub 2018 Aug 31. PubMed 30177236 ↗

Related links

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Data sharing will be consistent with the results submission policy of ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2016 to primary completion in Sep 2017, 13 months.

Results were first posted in Jun 2019, 1 year 8 months after primary completion. A results delay was requested in Sep 2018.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2016
First posted
Oct 21, 2016
StartActual
Aug 1, 2016
Primary completionActual
Sep 24, 2017
CompletionActual
Oct 19, 2017
Results delay requested
Sep 6, 2018
Results first posted
Jun 13, 2019
Last update
Oct 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02942004
Responsible party
Sponsor
First posted
Oct 21, 2016
Start date
Aug 1, 2016
Primary completion
Sep 24, 2017
Completion
Oct 19, 2017
Results posted
Jun 13, 2019
Last update
Oct 14, 2025

Study contacts

Helen Colquhoun, MD
study director · Sage Therapeutics

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Brexanolone

Start the discussion